Characterisation of a novel group B oncolytic adenovirus, ColoAd1

Characterisation of a novel group B oncolytic adenovirus, ColoAd1

Taispeáin leaganacha eile (1)

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Di, Y, Illingworth, S, Roesen, N, Fisher, K, Seymour, L
Formáid:	Journal article
Foilsithe / Cruthaithe:	2011

Míreanna comhchosúla

Characterisation of a novel group B oncolytic adenovirus, ColoAd1
de réir: Di, Y
Foilsithe / Cruthaithe: (2011)

Arming ColoAd1 with tumor necrosis factor alpha and lymphotoxin alpha
de réir: Koelen, J
Foilsithe / Cruthaithe: (2015)

Preclinical safety studies of enadenotucirev, a chimeric group B human-specific oncolytic adenovirus
de réir: Illingworth, S, et al.
Foilsithe / Cruthaithe: (2017)

Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
de réir: Sam Illingworth, et al.
Foilsithe / Cruthaithe: (2017-06-01)

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
de réir: Dyer, A, et al.
Foilsithe / Cruthaithe: (2016)

Bioprocessing of oncolytic group B adenovirus for scalable production
de réir: Cooper, L
Foilsithe / Cruthaithe: (2014)

Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth
de réir: Tedcastle, A, et al.
Foilsithe / Cruthaithe: (2016)

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
de réir: Arthur Dyer, et al.
Foilsithe / Cruthaithe: (2017-03-01)

Combining oncolytic adenovirus with radiation – a paradigm for the future of radiosensitization
de réir: O'Cathail, S, et al.
Foilsithe / Cruthaithe: (2017)

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.
de réir: Green, N, et al.
Foilsithe / Cruthaithe: (2012)

Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells
de réir: Lei, J, et al.
Foilsithe / Cruthaithe: (2018)

Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells
de réir: Janet Lei, et al.
Foilsithe / Cruthaithe: (2018-06-01)

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.
de réir: Bazan-Peregrino, M, et al.
Foilsithe / Cruthaithe: (2008)

Oncolytic Replication of E1b-Deleted Adenoviruses
de réir: Pei-Hsin Cheng, et al.
Foilsithe / Cruthaithe: (2015-11-01)

Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35
de réir: Ryosuke Ono, et al.
Foilsithe / Cruthaithe: (2021-03-01)

A Renaissance for Oncolytic Adenoviruses?
de réir: Paola Blanchette, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Oncolytic Adenoviruses in Cancer Treatment
de réir: Ramon Alemany
Foilsithe / Cruthaithe: (2014-02-01)

Oncolytic Adenoviruses in Gastrointestinal Cancers
de réir: Raquel T. Yokoda, et al.
Foilsithe / Cruthaithe: (2018-03-01)

Factors responsible for inhibition of adenovirus infection by cellular debris and tumour lysate
de réir: Tedcastle, A, et al.
Foilsithe / Cruthaithe: (2011)

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
de réir: Freedman, J, et al.
Foilsithe / Cruthaithe: (2017)

Adenovirus as a Vector and Oncolytic Virus
de réir: Wataru Matsunaga, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Oncolytic adenovirus for treatment of malignant ascites
de réir: Akseli Hemminki, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Increasing the Efficacy of Oncolytic Adenovirus Vectors
de réir: William S. M. Wold, et al.
Foilsithe / Cruthaithe: (2010-08-01)

Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
de réir: Hanni Uusi-Kerttula, et al.
Foilsithe / Cruthaithe: (2015-11-01)

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
de réir: Joshua D Freedman, et al.
Foilsithe / Cruthaithe: (2017-06-01)

NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer
de réir: Elaine Y.L. Leung, et al.
Foilsithe / Cruthaithe: (2020-03-01)

Ultrasound-enhanced delivery of polymer-coated oncolytic adenovirus for tumour growth inhibition
de réir: Carlisle, R, et al.
Foilsithe / Cruthaithe: (2011)

Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response
de réir: Calderon, H
Foilsithe / Cruthaithe: (2017)

Oncolytic adenoviruses and immunopeptidomics: a convenient marriage
de réir: Marc Garcia‐Moure, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Species D Adenoviruses as Oncolytic Viral Vectors
de réir: Brianna L. Bullard, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Cavitation-enhanced delivery of a self-amplifying oncolytic adenovirus for tumour-selective cancer therapy.
de réir: Carlisle, R, et al.
Foilsithe / Cruthaithe: (2012)

Novel Chitosan-Coated Liposomes Coloaded with Exemestane and Genistein for an Effective Breast Cancer Therapy
de réir: Shwetakshi Sharma, et al.
Foilsithe / Cruthaithe: (2024-02-01)

Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound.
de réir: Bazan-Peregrino, M, et al.
Foilsithe / Cruthaithe: (2013)

Antagonism of glycolysis and reductive carboxylation of glutamine potentiates activity of oncolytic adenoviruses in cancer cells
de réir: Dyer, A, et al.
Foilsithe / Cruthaithe: (2018)

Exploring the relationship between cancer metabolism and oncolytic adenoviruses
de réir: Dyer, A
Foilsithe / Cruthaithe: (2021)

In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
de réir: Victor A. Naumenko, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
de réir: Daoyuan Xie, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy
de réir: Ee Wern Tan, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
de réir: Gabriela Green-Tripp, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts
de réir: Jing Li Huang, et al.
Foilsithe / Cruthaithe: (2016-09-01)